D. E. Shaw & Co., Inc. Gsk PLC Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $16.3 Million - $18.5 Million	-387,177 Reduced 76.68%	117,760 $5.13 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $9.21 Million - $10.9 Million	-228,893 Reduced 31.19%	504,937 $22 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $28 Million - $32.6 Million	719,141 Added 4895.78%	733,830 $32.4 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $192,553 - $214,246	4,964 Added 51.04%	14,689 $561,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $1.67 Million - $1.9 Million	-45,820 Reduced 82.49%	9,725 $387,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $24.8 Million - $29 Million	-726,495 Reduced 92.9%	55,545 $2.04 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $24.6 Million - $27.7 Million	645,227 Added 471.61%	782,040 $29.4 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $26.7 Million - $30.7 Million	-704,710 Reduced 83.74%	136,813 $5.58 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $27.3 Million - $41.1 Million	841,523 New	841,523 $31.9 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $11.2 Million - $12.2 Million	-284,676 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $9.74 Million - $10.8 Million	-252,424 Reduced 47.0%	284,676 $11.9 Million
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $7.88 Million - $8.9 Million	208,390 Added 63.4%	537,100 $20.5 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $9.31 Million - $11 Million	-263,348 Reduced 44.48%	328,710 $11.7 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $23.4 Million - $24.6 Million	592,058	592,058 $24 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account